Abstract: According to one embodiment, a lighting device for vehicle includes a socket including a base portion, and a first protrusion portion which protrudes from one face of the base portion; and a light emitting module which is provided at the first protrusion portion, and includes a light emitting element. The socket contains a heat conductive resin of which heat conductivity is 7 W/(m•K) or more and 11 W/(m•K) or less. When a maximum dimension of the base portion in a direction orthogonal to a center axis of the lighting device for vehicle is set to A1 (mm), a maximum dimension of the first protrusion portion in a direction orthogonal to the center axis is set to A2 (mm), and power which is applied to the light emitting module is set to W (watt), (A1-A2)/W becomes 1.0 (mm/W) or more and 6.5 (mm/W) or less.

Abstract: According to one embodiment, a vehicle lighting device includes a flange portion; a storage portion that protrudes from one surface of the flange portion; and a light emitting module that is provided in an end portion of the storage portion on a side opposite to the flange portion side. The light emitting module includes a substrate; a first light emitting portion that is provided in the substrate, has a light emitting element, and emits white light; a second light emitting portion that is provided in the substrate, has a light emitting element, and emits red or amber light; a control portion that causes one of the first light emitting portion and the second light emitting portion to emit light; and a diffusion portion that has a light-transmitting property and covers the first light emitting portion and the second light emitting portion.

Abstract: A vehicle lamp according to an embodiment includes a lighting device; a housing where the lighting device is disposed; and a fixing unit pressing the lighting device against the housing. The lighting device has a flange portion; a storage portion protruding from one surface of the flange portion; and a light-emitting module disposed in the end portion of the storage portion on the side opposite to the flange portion side and having a light-emitting element. The housing has a hole where the storage portion is disposed. The fixing unit presses the flange portion against the housing in the vicinity of a peripheral edge of the hole where the storage portion is disposed.

Abstract: A lighting device includes a body section; a cover section provided on an end surface of the body section; and a light emitting module provided between the body section and the cover section, having a light emitting element. A position of the end section of the light emitting module is equal to a position of the end section of the body section, or is nearer to the side of the cover section than the position of the end section of the body section. The position of the end section on the side of the body section in a portion in which the cover section comes into contact with the body section is nearer to the side of the body section than the position of the end section of the light emitting module on the side of the cover section.

Abstract: A vehicle lighting device includes a light emitting unit, a holding unit, a light guide, a cover and an attachment unit. The light emitting unit has one or more light emitting elements. The holding unit holds the light emitting unit. The light guide guides light emitted from the light emitting unit and emits the light from a tip which is on a tip side opposite to a light emitting unit side. The cover has a first fixation unit to be fixed to the holding unit and a second fixation unit which has a diameter smaller than a diameter of the first fixation unit and internally fixes the light guide thereto in a state of exposing the tip. The attachment unit is formed in the second fixation unit in a shape attachable to a reflector.

Abstract: According to one embodiment, a lighting device for a moving body includes a substrate that has a base body having a plurality of connection sections on a side surface and a wiring pattern provided on at least one main surface of the base body; a light emitting element that is electrically connected to the wiring pattern; and an adhesive section that is provided between the base body and a body section. The connection sections are at least one of groove sections, concave sections, and convex sections. The adhesive section covers at least a part of the plurality of connection sections.

Abstract: A lighting device according to an embodiment includes a socket unit, a light emitting unit, and a lid unit. The light emitting unit is provided in an accommodation unit of the socket unit, and includes a light emitting element. The lid unit closes the accommodation unit of the socket unit, and is formed with an opening portion which causes light radiated from the light emitting element to pass through. An end face of the light emitting unit on the opening portion side overlaps with the opening portion in the thickness direction of the lid unit, and is located on the light emitting unit side rather than an end face of the lid unit on a side opposite to the light emitting unit side.

Abstract: A light emitting module according to an exemplary embodiment includes a board that is provided with a wiring pattern, a light emitting element that is electrically connected to the wiring pattern, a surrounding wall member that is provided on the board via a joining portion containing a resin and surrounds the light emitting element, and a first coating portion that contains the same resin as the resin contained in the joining portion, and covers an exposed portion of the wiring pattern outside the surrounding wall member.

Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.

Abstract: A light emitting device according to an embodiment includes: a main body section; a light emitting section provided in the main body section and including a light emitting element; a cover provided on a side of the main body section where the light emitting section is provided; and an adhesive section provided between the main body section and the cover in a part of a region on the side of the main body section where the light emitting section is provided.

Abstract: According to one embodiment, a lighting device includes: a body section; a cover section provided on an end surface of the body section; and a light emitting module provided between the body section and the cover section, having a light emitting element. A position of the end section of the light emitting module is equal to a position of the end section of the body section, or is nearer to the side of the cover section than the position of the end section of the body section. The position of the end section on the side of the body section in a portion in which the cover section comes into contact with the body section is nearer to the side of the body section than the position of the end section of the light emitting module on the side of the cover section.

Abstract: According to one embodiment, a lighting device includes: a light emitting section that has a light emitting element; a light guide that is provided on a side of radiation of light of the light emitting section; and a reflection section that is provided in an end section of the light guide on the side opposite the side of the light emitting section and includes a through hole that exposes the light guide and a first reflection surface that is inclined in a direction in which a side of the light emitting section approaches a side of a center shaft of the light guide.

Abstract: A vehicle lighting device according to embodiments includes a light emitting unit, a holding unit, a light guide, a cover and an attachment unit. The light emitting unit has one or more light emitting elements. The holding unit holds the light emitting unit. The light guide guides light emitted from the light emitting unit and emits the light from a tip which is an opposite side to the light emitting unit side. The cover has a first fixation unit to be fixed to the holding unit and a second fixation unit which has a diameter smaller than that of the first fixation unit and internally fixes the light guide thereto in a state of exposing the tip. The attachment unit attaches the vehicle lighting device to a light emitting object (lamp) to which the light guided from the light guide is emitted, and is formed in the second fixation unit.

Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.

Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.

Abstract: The present invention provides a fused polycyclic compound of the following formula, analogues thereof and pharmaceutically acceptable salts thereof; and agents for increasing the sugar-transporting capacity, hypoglycemic agents and pharmaceutical compositions containing the above compounds. This fused polycyclic compound has high medicinal properties and few side-effects, and a therapeutic effect on diabetes. wherein R represents an alkoxy group, R? represents an oxazolylpropionyl group or a thiazolylpropionyl group, and R? represent a hydrogen atom.

Abstract: By searching various kinds of compounds having CaSR agonistic activity, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise the compound. More specifically, the present invention provides CaSR agonistic agents, pharmaceutical compositions, preventive or therapeutic agents for diarrhea and kokumi-imparting agents each of which comprise a glutamic acid derivative having CaSR agonistic activity or pharmaceutically acceptable salts thereof.

Abstract: The present invention provides a fused polycyclic compound of the following formula, analogues thereof and pharmaceutically acceptable salts thereof; and agents for increasing the sugar-transporting capacity, hypoglycemic agents and pharmaceutical compositions containing the above compounds. This fused polycyclic compound has high medicinal properties and few side-effects, and a therapeutic effect on diabetes. wherein R represents an alkoxy group, R? represents an oxazolylpropionyl group or a thiazolylpropionyl group, and R? represent a hydrogen atom.

Abstract: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.

Abstract: The present invention provides a fused polycyclic compound of the following formula, analogues thereof and pharmaceutically acceptable salts thereof; and agents for increasing the sugar-transporting capacity, hypoglycemic agents and pharmaceutical compositions containing the above compounds. This fused polycyclic compound has high medicinal properties and few side-effects, and a therapeutic effect on diabetes. wherein R represents an alkoxy group, R? represents an oxazolylpropionyl group or a thiazolylpropionyl group, and R? represent a hydrogen atom.